ArticleInternational journal of general medicine2026
A Retrospective Study of Preventive Anticoagulant Therapy Among Trauma Patients in Yichang Area Through Clinical Data Review and Clinician Survey.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unaddressed Biases in a Retrospective Study of Anticoagulant Prophylaxis in Trauma Patients [Letter].International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trauma-induced coagulopathy is one of the important causes for deaths after trauma. This study aimed to explore the current state of preventive anticoagulation therapy and the clinical factors affecting the application of anticoagulation guidelines. Methods: This study retrospectively involved 787 trauma patients treated at our hospital from January 2017 to November 2022 via review of medical records. A questionnaire survey was assigned to the clinicians to evaluate the current methods and opinions on preventive anticoagulation therapy. The time of the first anticoagulation therapy refers to the time from admission to the initiation of the first anticoagulation treatment. Results: A total of 787 trauma patients were included in this study, of whom 68.74% received anticoagulant therapy, mainly using low-molecular-weight heparin calcium. Thrombotic events happened in 14.61% of these patients. Binary logistic regression analysis showed that age, injury severity score, length of hospital stay, presence or absence of thrombotic events, and whether or not lower extremity vascular ultrasound and pulmonary CT re-examination were performed were significant factors affecting the use or non-use of anticoagulation therapy. A significant association was found between the daily dose of anticoagulant (P < 0.001) and the occurrence of thrombotic events, as well as between the time of the first anticoagulation therapy (P < 0.001) and the occurrence of thrombotic events. Logistic regression analysis showed that age, department of first visit, daily dose of anticoagulant drugs, time of first anticoagulation and the lower extremity vascular ultrasound and lung CT were reexamined were significant factors affecting the occurrence of thrombotic events (P<0.05). The questionnaire showed that 97% of physicians consider prophylactic anticoagulant therapy for trauma patients but there were significant differences in the choice and practice of anticoagulant therapy among different departments. Conclusion: The current study showed that multiple factors may significantly associate with the use or non-use of anticoagulation therapy and the occurrence of thrombotic events. There were also significant differences in the method and opinions in treating trauma patients and using anticoagulation therapy among different clinicians from different departments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.